Docoh
Loading...

STIM Neuronetics

News

From Benzinga Pro
5 Penny Stocks Insiders Are Buying
26 Nov 21
News, Penny Stocks, Insider Trades, Pre-Market Outlook, Markets, Trading Ideas
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Neuronetics To Participate At The Piper Sandler 33rd Annual Virtual Healthcare Conference
22 Nov 21
News, Events
Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders,
Neuronetics Q3 EPS $(0.31) Misses $(0.30) Estimate, Sales $13.80M Miss $14.10M Estimate
9 Nov 21
Earnings, News
Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.30) by 3.33 percent. This is a 72.22 percent decrease over losses of $(0.18) per share from the
Earnings Scheduled For November 9, 2021
9 Nov 21
Earnings, M&A, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter. • KT (NYSE:KT) is projected to report earnings for its third quarter.
Neuronetics, River Region Psychiatry Announce Exclusive Partnership
8 Nov 21
News, Contracts
Neuronetics, Inc. (NASDAQ:STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders,
Neuronetics Highlights Launch Of Upgrade For NeuroStar Advanced Therapy System
19 Oct 21
News
Neuronetics, Inc. (NASDAQ:STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders
JMP Securities Maintains Market Outperform on Neuronetics, Lowers Price Target to $12
14 Oct 21
News, Price Target, Analyst Ratings
JMP Securities analyst David Turkaly maintains Neuronetics (NASDAQ:STIM) with a Market Outperform and lowers the price target from $18 to $12.
50 Biggest Movers From Yesterday
14 Oct 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target.
Mid-Afternoon Market Update: Nasdaq Jumps 100 Points; Jasper Therapeutics Shares Spike Higher
13 Oct 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Toward the end of trading Wednesday, the Dow traded up 0.06% to 34,398.86 while the NASDAQ rose 0.70% to 14,566.72. The S&P also rose, gaining 0.31% to 4,364.35.
12 Health Care Stocks Moving In Wednesday's Intraday Session
13 Oct 21
Intraday Update, Markets, Movers
Mid-Day Market Update: Gold Surges 2%; Neuronetics Shares Plunge
13 Oct 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Midway through trading Wednesday, the Dow traded down 0.43% to 34,229.72 while the NASDAQ rose 0.40% to 14,524.02. The S&P also fell, dropping 0.10% to 4,346.21.
39 Stocks Moving In Wednesday's Mid-Day Session
13 Oct 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares jumped 113% to $15.36 after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target.
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2021
13 Oct 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Upgrades
Mid-Morning Market Update: Markets Mixed; JPMorgan Posts Upbeat Earnings
13 Oct 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Following the market opening Wednesday, the Dow traded down 0.36% to 34,254.62 while the NASDAQ rose 0.27% to 14,505.47. The S&P also fell, dropping 0.07% to 4,347.49.
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
13 Oct 21
Pre-Market Outlook, Markets, Movers
The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal
13 Oct 21
Biotech, Earnings, News, Penny Stocks, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours.
20 Stocks Moving in Wednesday's Pre-Market Session
13 Oct 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Puxin Limited (NYSE: NEW) rose 52.1% to $0.6901 in pre-market trading after dipping 24% on Tuesday.
BTIG Downgrades Neuronetics to Neutral
13 Oct 21
News, Downgrades, Analyst Ratings
BTIG analyst Marie Thibault downgrades Neuronetics (NASDAQ:STIM) from Buy to Neutral.
Neuronetics Reports Commercial Deal With Success TMS
5 Oct 21
News, Contracts
Neuronetics, Inc. (NASDAQ:STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders,
Neuronetics' NeuroStar Mental Health Therapy Shows Better Safety Over H-Coil TMS
21 Sep 21
News, Health Care, Movers, Trading Ideas, General

Press releases

From Benzinga Pro
Neuronetics to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference
22 Nov 21
News, Press Releases
MALVERN, Pa., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life
IMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERS
11 Nov 21
Press Releases
MARLTON, N.J., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Impulse Dynamics N.V., a company dedicated to improving the lives of people with heart failure (HF), today announced the election of five new members to its Board of
Anika Appoints Sheryl Conley to Board of Directors
1 Nov 21
News, Management, Press Releases
BEDFORD, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ:ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that its Board of Directors has
Neuronetics Celebrates 235,000 Treatment Milestone for Success TMS
26 Oct 21
Health Care, Press Releases
MALVERN, Pa., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life
Neuronetics Launches Upgrades of NeuroStar® Advanced Therapy for Mental Health
19 Oct 21
Health Care, Press Releases, General
System Innovations Improve Efficiencies for Healthcare Practices and Patients MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial-stage medical technology company focused on
A.I. Breakthrough Could Disrupt the $11 Trillion Medical Sector
18 Oct 21
Small Cap, Opinion, Press Releases
LONDON, Oct. 18, 2021 /PRNewswire/ -- A massive disruption now appears imminent in one of the world's largest – and most important – industries. In much the same way that Amazon disrupted the retail business – and
The Law Offices of Frank R. Cruz Announces Investigation of Neuronetics, Inc. (STIM) on Behalf of Investors
14 Oct 21
Penny Stocks, Press Releases
The Law Offices of Frank R.
Neuronetics Announces Preliminary Revenue for Third Quarter 2021
12 Oct 21
Press Releases
MALVERN, Pa., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life
Neuronetics Announces Commercial Agreement with Success TMS
5 Oct 21
Health Care, Press Releases
MALVERN, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life
NeuroStar® Advanced Therapy Recognizes National Depression Education and Awareness Month With New Campaign Launch
4 Oct 21
Health Care, Press Releases
MALVERN, Pa., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life
Neuronetics and Zion Healing Announce First Franchise Model for TMS Clinics
7 Sep 21
Health Care, Press Releases
MALVERN, Pa. and ST. GEORGE, Utah, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve